EMCDDA zveřejňuje svou první zprávu o zdravotních reakcích na nové psychoaktivní látky
Během posledního desetiletí došlo k bezprecedentnímu nárůstu počtu nových léků, které se objevují na světovém trhu
Join as an individual or organization
In the first long-term follow-up of patients treated with buprenorphine/naloxone (Bp/Nx) for addiction to opioid pain relievers, half reported that they were abstinent from the drugs 18 months after starting the therapy. After 3.5 years...
The aim of this draft discussion paper, “From coercion to cohesion: Treating drug dependence through health care, not punishment”, is to promote a health-oriented approach to drug dependence. The International Drug Control Conventions give...